Biontech SE

NASDAQ:BNTXUnited States

Nov 13, 2024

Show headlines and story abstract

• European Equities Traded in the US as American Depositary Fall in Wednesday Trading, from 10:59AM ET on Wednesday Nov 13, 2024 by MT Newswires

  10:59AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: ING, NVO, PSO, SAP, TRIB, VOD, SQNS, GRFS, VRNA, AKTX, BCYC, BNTX, BCS, EVAX, TCBP, MTLS
  10:59 AM EST, 11/13/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.76% to 1,307.21 on the S&P Europe Select ADR Index. From continental Europe, the gain...

• DJ BioNTech to Acquire Biotheus in $950 Million Deal, from 7:09AM ET on Wednesday Nov 13, 2024 by Dow Jones

  7:09AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: BNTX
  
  By Dean Seal
  
  BioNTech has agreed to acquire biotechnology company Biotheus for $800 million up front and up to $150 million in milestone payments.
  
  The German developer of RNA vaccines and immunotherapies said Wednesday that the acquisition builds on its oncology strategy and provides it with full global rights to an investigational antibody being developed to fight tumors.
  

• BioNTech to Acquire Biotheus; Shares Rise Pre-Bell, from 7:05AM ET on Wednesday Nov 13, 2024 by MT Newswires

  7:05AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: BNTX
  07:05 AM EST, 11/13/2024 (MT Newswires) -- BioNTech (BNTX) said Wednesday it has agreed to acquire biotechnology company Biotheus. Under the terms of the deal, BioNTech will acquire 100% of Biotheus for $800 million, mainly in cash with a small port...